Results 11 to 20 of about 213,160 (266)
Targeting Aggrephagy for the Treatment of Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in older individuals with specific neuropsychiatric symptoms. It is a proteinopathy, pathologically characterized by the presence of misfolded protein (Aβ and Tau ...
Sandeep Malampati +14 more
doaj +1 more source
Clinical Characteristics of Involuntary Movement in Hospitalized Patients [PDF]
Objective Neurological symptoms in hospitalized patients are not rare, and neurological consultation for movement disorders is especially important in evaluating or managing those with various movement disorders.
Kyum-Yil Kwon +3 more
doaj +1 more source
Deep learning algorithm reveals two prognostic subtypes in patients with gliomas
Background Gliomas are highly complex and heterogeneous tumors, rendering prognosis prediction challenging. The advent of deep learning algorithms and the accessibility of multi-omic data represent a new approach for the identification of survival ...
Jing Tian +10 more
doaj +1 more source
Palliative care for Parkinson’s disease: suggestions from a council of patient and carepartners
In 2015, the Parkinson’s Disease Foundation sponsored the first international meeting on Palliative Care and Parkinson’s disease and the Patient Centered Outcomes Research Institute funded the first comparative effectiveness trial of palliative care for ...
Kirk Hall +4 more
doaj +1 more source
How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease
ObjectiveFreezing of gait (FoG) is a debilitating problem in patients with PD. The multifactorial pathogenesis of FoG remains poorly understood. We aimed to find which factors are most strongly associated with the occurrence of FoG.MethodsThree hundred ...
Paola Ortelli +9 more
doaj +1 more source
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease.
Simon R. W. Stott +2 more
doaj +1 more source
Internal responsiveness of HRQoL in the stable patient group. (DOCX 20 kb)
Tu, Xiao-Jing +3 more
openaire +1 more source
MOESM2 of White matter damage and systemic inflammation in Parkinsonâ s disease
Additional file 2: Partial correlation between DTI indices and clinical disease severity.
Chiang, Pi-Ling +7 more
openaire +1 more source
MOESM1 of White matter damage and systemic inflammation in Parkinsonâ s disease
Additional file 1: Supplementary methods of DTI data preprocessing and analysis.
Chiang, Pi-Ling +7 more
openaire +1 more source
Additional file 1: of Cerebellar involvement in Parkinsonâ s disease resting tremor
Summary Analysis Data. (DOCX 13 kb)
Lefaivre, Shannon +2 more
openaire +1 more source

